Indeed, it was demonstrated that brain-derived EVs (Brain-EVs) can be isolated from plasma samples of patient and harness specific disease-related proteins, such as beta-amyloid and phosphorylated forms of tau in Alzheimer’s disease patients [122,123,124]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.